NASDAQ:CNCE
Delisted
Concert Pharmaceuticals Stock News
$8.37
+0 (+0%)
At Close: May 30, 2023
Dupont Capital Management Corp Makes New $304,000 Investment in Concert Pharmaceuticals Inc (NASDAQ:CNCE)
06:24am, Wednesday, 05'th Aug 2020
Dupont Capital Management Corp purchased a new position in Concert Pharmaceuticals Inc (NASDAQ:CNCE) during the second quarter, HoldingsChannel reports. The institutional investor purchased 30,525 sha
Will Concert Pharmaceuticals (CNCE) Report Negative Q2 Earnings? What You Should Know
04:33pm, Thursday, 30'th Jul 2020
Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Concert Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 6, 2020
11:00am, Thursday, 30'th Jul 2020
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its second quarter 2020 financial results on Thursday, August 6, 2020, before the U.S. financial markets open. The Comp
CTPark Bucharest North, a 65 million EUR investment of CTP, will open its first operational spaces in Autumn 2020 - Business Review
09:43am, Wednesday, 29'th Jul 2020
CTP, the leading premium industrial parks developer and long-term manager in Romania and Central and Eastern Europe, continues its expansion in Romania by
Concert Pharmaceuticals Receives FDA Breakthrough Therapy Designation for CTP-543 for the Treatment of Alopecia Areata
11:00am, Wednesday, 08'th Jul 2020
The FDA granted Breakthrough Therapy Designation for CTP-543 for the treatment of moderate-to-severe alopecia areata.
Need To Know: Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Insiders Have Been Buying Shares
03:44pm, Monday, 06'th Jul 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Hedge Fund Sentiment Is Stagnant On Concert Pharmaceuticals Inc (CNCE)
01:30pm, Monday, 06'th Jul 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
$10,000.00 in Sales Expected for Concert Pharmaceuticals Inc (NASDAQ:CNCE) This Quarter
04:12am, Sunday, 05'th Jul 2020
Brokerages predict that Concert Pharmaceuticals Inc (NASDAQ:CNCE) will announce $10,000.00 in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Con
Concert Pharmaceuticals (NASDAQ:CNCE) Stock Rating Upgraded by Zacks Investment Research
07:08am, Saturday, 04'th Jul 2020
Zacks Investment Research upgraded shares of Concert Pharmaceuticals (NASDAQ:CNCE) from a hold rating to a buy rating in a research note issued to investors on Tuesday, Zacks.com reports. Zacks Invest
Concert Pharmaceuticals Inc (NASDAQ:CNCE) Shares Sold by Squarepoint Ops LLC
06:23am, Saturday, 04'th Jul 2020
Squarepoint Ops LLC reduced its position in Concert Pharmaceuticals Inc (NASDAQ:CNCE) by 29.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4
Concert (CNCE) Upgraded to Buy: Here's Why
04:00pm, Tuesday, 30'th Jun 2020
Concert (CNCE) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Concert Pharmaceuticals (CNCE) Stock Outpacing Its Medical Peers This Year?
03:30pm, Tuesday, 30'th Jun 2020
Is (CNCE) Outperforming Other Medical Stocks This Year?
5 Bonus Battery Stories — Cobalt-Free Batteries, Battery Reuse ...
08:06pm, Saturday, 27'th Jun 2020
Following up on 7 bonus solar + storage articles — very cool stories that we just didn't get to covering in standalone pieces — here are 5 bonus electric vehicle battery stories.
Insider Sells Concert Pharmaceuticals' Shares
02:39pm, Wednesday, 24'th Jun 2020
Shares of Concert Pharmaceuticals Inc (NASDAQ:CNCE) fell by 1.8% from the previous closing price. Stuart Nancy filed a Form 4 with the SEC on Wednesday, June 24. The insider sold 10,295 shares at an a
Pupils pay tribute to inspirational history teacher James Furlong
07:06am, Monday, 22'nd Jun 2020
Joe Ritchie-Bennett, from Philadelphia in the US, had been working for a Dutch pharmaceutical company in Reading, Berkshire, and lost his husband Ian, 32, to colon cancer in 2014.